Literature DB >> 15852374

Neuroprotection by the PGE2 EP2 receptor in permanent focal cerebral ischemia.

Dong Liu1, Liejun Wu, Richard Breyer, Mark P Mattson, Katrin Andreasson.   

Abstract

Recent studies suggest a neuroprotective function of the PGE2 EP2 receptor in excitotoxic neuronal injury. The function of the EP2 receptor was examined at time points after excitotoxicity in an organotypic hippocampal model of N-methyl-D-aspartate (NMDA) challenge and in a permanent model of focal forebrain ischemia. Activation of EP2 led to significant neuroprotection in hippocampal slices up to 3 hours after a toxic NMDA stimulus. Genetic deletion of EP2 resulted in a marked increase in stroke volume in the permanent middle cerebral artery occlusion model. These findings support further investigation into therapeutic strategies targeting the EP2 receptor in stroke.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15852374     DOI: 10.1002/ana.20461

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  69 in total

1.  Function of prostaglandin E2 EP receptors in the acute outcome of rodent hypoxic ischemic encephalopathy.

Authors:  Hidetoshi Taniguchi; Christoph Anacker; Gabriela Beatriz Suarez-Mier; Qian Wang; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2011-09-12       Impact factor: 3.046

Review 2.  Molecular and cellular immune mediators of neuroprotection.

Authors:  Nicolas P Turrin; Serge Rivest
Journal:  Mol Neurobiol       Date:  2006-12       Impact factor: 5.590

3.  Inflammation after stroke: mechanisms and therapeutic approaches.

Authors:  Muzamil Ahmad; Steven H Graham
Journal:  Transl Stroke Res       Date:  2010-06       Impact factor: 6.829

Review 4.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

5.  Soluble neuroprotective antioxidant uric acid analogs ameliorate ischemic brain injury in mice.

Authors:  Frank Haberman; Sung-Chun Tang; Thiruma V Arumugam; Dong-Hoon Hyun; Qian-Sheng Yu; Roy G Cutler; Zhihong Guo; Harold W Holloway; Nigel H Greig; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2007-08-10       Impact factor: 3.843

6.  Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death.

Authors:  Thiruma V Arumugam; Sung-Chun Tang; Justin D Lathia; Aiwu Cheng; Mohamed R Mughal; Srinivasulu Chigurupati; Tim Magnus; Sic L Chan; Dong-Gyu Jo; Xin Ouyang; David P Fairlie; Daniel N Granger; Alexander Vortmeyer; Milan Basta; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-21       Impact factor: 11.205

7.  Divergent effects of prostaglandin receptor signaling on neuronal survival.

Authors:  Liejun Wu; Qian Wang; Xibin Liang; Katrin Andreasson
Journal:  Neurosci Lett       Date:  2007-06-07       Impact factor: 3.046

8.  Neuroprotection by selective allosteric potentiators of the EP2 prostaglandin receptor.

Authors:  Jianxiong Jiang; Thota Ganesh; Yuhong Du; Pahk Thepchatri; Asheebo Rojas; Iestyn Lewis; Serdar Kurtkaya; Lian Li; Min Qui; Geidy Serrano; Renee Shaw; Aiming Sun; Ray Dingledine
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-14       Impact factor: 11.205

9.  COX2 inhibitors for acquired brain injuries: is the time ripe?

Authors:  Kenneth I Strauss
Journal:  Crit Care Med       Date:  2010-02       Impact factor: 7.598

10.  Inhibiting the PGE2 Receptor EP2 Mitigates Excitotoxicity and Ischemic Injury.

Authors:  Lexiao Li; Ying Yu; Ruida Hou; Jiukuan Hao; Jianxiong Jiang
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.